Russian Reports of Agreement to Produce Sputnik V in France Denied

Reading Time: < 1 minute

None of France’s pharmaceutical companies have signed a contract with Russia to produce its Sputnik V COVID-19 vaccine, a spokesman for France’s industry ministry said on Tuesday. The French reaction followed media reports by the head of Russia’s RDIF sovereign wealth fund stating an agreement had been sealed. Earlier, the head of RDIF said his organization had struck deals with production facilities in Italy, Spain, France and Germany to manufacture the Russian vaccine. “We have not identified a site which meets their requirements,” the French spokesperson added.

Source: Euractiv

CET Editor

Recent Posts

US soldiers die during Lithuania training exercise

A total of three US soldiers were found dead while a fourth remains missing after…

1 day ago

Trump-Putin detente could revive Nord Stream 2

The US and Russia are discussing the potential reopening of the Nord Stream 2 gas…

1 day ago

Dodik dodges arrest warrant, surfaces in Moscow

Republika Srpska (RS) President Milorad Dodik announced that he had arrived in Moscow on Monday…

1 day ago

CEE startups outpace Western Europe rivals

Startups in Central and Eastern Europe (CEE) are growing faster than in Western Europe and…

1 day ago

Gender pay gaps remain in CEE, despite EU efforts

Romania and Poland have gender pay disparities among the lowest in the EU, according to…

1 week ago

Europe’s trilemma: rearmament, green transition, competitiveness

European leaders met in Brussels on 20 March to confront a mounting policy dilemma: how…

1 week ago